Discover 381 paid clinical trials in Greenville, South Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 381
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for
Non-cystic Fibrosis Bronchiectasis
Location: Spartanburg SC, Union SC, Augusta GA, Atlanta GA,
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All
Age: 18 - 70+
Code: NCT06559150
Phase 2, Recruiting
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Location: Anderson SC, Gastonia NC, Winston-Salem NC, Richmond VA,
Sponsor: Trevi Therapeutics
Sex: All
Age: 40+
Code: NCT07671911
Phase 3, Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
for
Atrial Fibrillation (AF)
Location: Anderson SC, Concord NC, Johns Creek GA, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07430956
Phase 3, Recruiting
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry
for
Soft Tissue Lesion
Location: Anderson SC, Durham NC, Morgantown WV, Wynnewood PA,
Sponsor: Galvanize Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05851430
Recruiting
TR(ACE) Assay Clinical Specimen Study
for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: Greenville SC, Knoxville TN, Bloomington IN,
Sponsor: Biological Dynamics
Sex: All
Age: 21+
Code: NCT02934360
Recruiting
Mindful Walking for Adults With Chronic Pain
for
Chronic Pain
Location: Clemson SC
Sponsor: Clemson University
Sex: All
Age: 18+
Code: NCT06088329
Recruiting
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors